Pursuant to the correction that has taken place in recent weeks with respect to the shares in Huntsman Corporation, further downside risk now appears limited by close and important technical support levels at 28.1 USD. Investors have an opportunity to buy the stock and target the $ 32.2.
The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
The company has solid fundamentals for a short-term investment strategy.
The close medium term support offers good timing for purchasing the stock.
The group's high margin levels account for strong profits.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Its low valuation, with P/E ratio at 9.31 and 9.03 for the ongoing fiscal year and 2019 respectively, makes the stock pretty attractive with regard to earnings multiples.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Over the last twelve months, the sales forecast has been frequently revised upwards.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.